about
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.Investigation of the potential utility of a linomide analogue for treatment of choroidal neovascularization.Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.Genetic markers of pigmentation are novel risk loci for uveal melanoma.Germline BAP1 mutations misreported as somatic based on tumor-only testingFrequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.Germline BAP1 alterations in familial uveal melanoma.The chick eye in vision research: An excellent model for the study of ocular disease.MET oncogene inhibition as a potential target of therapy for uveal melanomas.Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimensHigh frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection.MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment.Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinomaOral Selumetinib Does Not Negatively Impact Photoreceptor Survival in Murine Experimental Retinal DetachmentHeterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predispositionAnalysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patientsComprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families WorldwideTranscriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma ProgressionMIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american populationGermline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer
P50
Q33697377-ACB08335-5532-4F4F-BBC9-39ACBEFEF845Q33740172-75AA4883-AD7A-4D6A-8026-F42D7AE2C368Q34218657-80B66D5E-0627-4AFE-B807-008F59605A23Q34961980-E12E40B5-1F1D-4E38-92F7-3B50815C5C72Q37157463-42046AFC-249C-4E12-B502-F36B9A37D631Q37171825-D3EAAE3B-FB32-4563-B560-88921C3D95FEQ37412184-CA20E179-B8B3-480C-AB67-55210D219E43Q37691345-AF382079-C963-425A-9468-A01CC4B2D8AEQ38201794-91486BA0-E5B7-4511-BDC0-0B06519C6298Q38373526-17CFC829-3DEE-4D4C-A567-B1138FF5C026Q38805682-67FF8E77-C2C5-4DE2-AD3F-3E2126C0EAE4Q39408739-97172736-3426-4627-BA97-7FAAD836D3C0Q39738016-8CE882C7-367C-43BD-9763-C98DDD7E755CQ41983928-449223FE-F485-4CB0-B76F-1C64D9D95ECCQ43509621-FF97CC90-B812-4DEB-A769-75349D843453Q45953158-B47D0436-6B53-4772-8EC3-09FF4F2E3985Q47586517-A7069977-358F-43E2-8436-B1D1AF900AF5Q49698247-1EA5943A-BBB1-4A05-83C3-526F8F92C014Q51783814-11F58E68-3C8D-4E44-BFDF-C70CDD540893Q57112789-7B109D67-C938-4C26-9373-46413085F5E6Q61452843-B51DAAAC-70C9-4EBA-B0CD-15524E1F6BB9Q64949664-080B666D-C726-4E7F-8A44-CE6E5A3B3527Q82436575-3A4846E6-A144-42E3-86C3-E510821DAF80Q88674603-81A05204-A597-440C-B802-C440827F922BQ90281138-C6844FE8-15E8-4FD2-A666-54ABA52AB6AFQ91104344-FF8670EC-5647-47AC-9A44-3CFD3F150D39Q92158202-C6C044DB-D9A2-496C-9FA8-7E1931F4CA02Q92446122-2B24E9BC-6CDC-4E16-BE51-60C2549D979D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9493-7894
@en
name
Mohamed H Abdel-Rahman
@ast
Mohamed H Abdel-Rahman
@en
Mohamed H Abdel-Rahman
@nl
type
label
Mohamed H Abdel-Rahman
@ast
Mohamed H Abdel-Rahman
@en
Mohamed H Abdel-Rahman
@nl
prefLabel
Mohamed H Abdel-Rahman
@ast
Mohamed H Abdel-Rahman
@en
Mohamed H Abdel-Rahman
@nl
P106
P31
P496
0000-0002-9493-7894